期刊文献+

Fabry病累及心脏的临床和影像学特征 被引量:4

Fabry's disease: clinical features and imaging findings
下载PDF
导出
摘要 目的分析和总结Fabry病患者心脏受累的临床表现和影像学特征,旨在提高对该病的认识和诊断。材料与方法经病理证实Fabry病累及心脏的1例男性49岁患者,先后行心电图、超声心动图、肾小球滤过率(GFR)测定、选择性冠状动脉造影、主动脉增强CT及磁共振(MRI)检查。结果患者心电图示左心室高电压、一度房室传导阻滞和ST-T改变。超声心动图示左心室壁普遍增厚,左室流出道梗阻,二尖瓣SAM征(+)。双肾肾小球滤过率(GFR)明显减低,双肾摄取及清除功能明显减低。主动脉增强CT未见夹层等异常征象,双肾动脉未见狭窄。冠状动脉造影未见冠状动脉狭窄或阻塞性病变。MRI示左心房扩大,左心室心肌肥厚,延迟扫描示室间隔、左心室前壁及下后壁基底段肌壁间异常强化。结论 Fabry病临床表现多样,综合临床病史、其他系统受累症状及MRI多序列成像,有助于该病的诊断与鉴别诊断。 Objective:One typical case with Fabry's disease was reported and a series of clinincal and imaging characteristics were reviewed to identify different types of cardiomyopathy. Materials and Methods:A 49-year-old male patient presented chest pain. ECG, echocardiography, selective coronary artery angiography and MR1 were performed. Results:ECG showed left ventricular hypertrophy, first degree of atrioventricular block and ST-T change. Echocardiography showed left ventricular hypertrophy, left ventricular outlfow obstruction and SAM sign (+). Selective coronary artery angiography demonstrated no coronary artery stenosis. MRI showed diffuse myocardial hypertrophy associated with delayed enhancement involving septal, anterial and inferolateral wall of basal segment of left ventricle. Conclusions:Patients with Fabry’s disease may have varied clinical manifestations. Clincal history, multisystemic involvement and delayed enhancement MRI may be helpful to the diagnosis.
出处 《磁共振成像》 CAS CSCD 2014年第5期348-351,共4页 Chinese Journal of Magnetic Resonance Imaging
关键词 法布里病 α半乳糖苷酶 磁共振成像 Fabry disease Alpha-galactosidase Magnetic resonance imaging
  • 相关文献

参考文献10

  • 1Desnick RJ,Brady R,Barranger J,et a1.Fabry disease,an underrecognized multisystemic disorder:expert recommendations for diagnosis,management,and enzyme replacement therapy.Ann Intern Med,2003,138(4):338-346.
  • 2ShaIl JS,Lee P,Hushes D,et al.The natural history of left ventficular systolic function in Anderson-Fabry disease.Heart,2005,91(4):533-534.
  • 3Pinderski LJ,Strotmann J.Congestive heart failure in Fabry cardiomyopathy:natural history experience in an international cohort of 1448 patients.J Heart Lung Transplant,2006,25(Suppl):S70.
  • 4Sachdev B,Takenaka T,Teraguchi H,et al.Prevalence of AndersonFabry disease in male patients with late onset hypertrophic cardiomyopathy.Circulation,2002,105(12):1407-1411.
  • 5Chimenti C,Pieroni M,Morgante E,et al.Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy.Circulation,2004,110(9):1047-1053.
  • 6De Cobelli F,Esposito A,Belloni E,et al.Delayed-enhanced cardiac MRI for differentiation of Fabry’s disease from symmetric hypertrophic cardiomyopathy.AJR Am J Roentgenol,2009,192(3):W97-102.
  • 7Imbriaco M,Spinelli L,Cuocolo A,et al.MRI characterization of myocardial tissue in patients with Fabry’s disease.AJR Am J Roentgenol,2007,188(3):850-853.
  • 8Shah JS,Hughes DA,Sachdev B,et al.Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease.Am J Cardiol,2005,96(6):842-846.
  • 9Linhart A,Kampmann C,Zamorano JL,et al.Cardiac manifestations of Anderson-Fabry disease:results from the international Fabry outcome survey.Eur Heart J,2007,28(10):1228-1235.
  • 10Kampmann C,Baehner F,Whybra C,et al.Cardiac manifestations of Anderson-Fabry disease in heterozygous females.J Am Coll Cardiol,2002,40(9):1668-1674.

同被引文献30

  • 1杨松娜.左室流出道梗阻继发感染性二尖瓣穿孔的超声心动图2例[J].中国超声医学杂志,2005,21(7):548-550. 被引量:3
  • 2de Couto G, Liu W, Tseliou E, et al. Macrophages mediate cardioprotective cel|ular postconditioning in acute myocardial infarction [J]. JClin Invest, 2015, 125, 125 (8): 3147-3162.
  • 3Hao K, Takahashi J, Ito K, et al. Clinical Characteristics of Patients With Acute Myocardial Infarction Who Did Not Undergo Primary Percutaneous Coronary Intervention - Report From the MIYAGI - AMI Registry Study [J]. Cire J, 2015, 79 (9): 2009-2016.
  • 4Shu J, Ren N, Du JB, et al. Increased levels of interleukio-6 and matrix metalloproteinase - 9 are of cardiac origin in acute coronary syndrome [J]. Scand Cardiovasc J, 2007, 41 (3): 149-154.
  • 5Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by lung- term therapy in patients undergoing percutaneous coronary intervention: the PCI - CURE study [J]. Lancet, 2001, 358 (9281): 527-533.
  • 6Dayer C, Stamenkovic I. Recruitment of Matrix Metalloproteinase -9 (MMP-9) to the Fibroblast Cell Surface by Lysyl Hydroxylase 3 (LH3) Triggers Transfomaing Growth Factor-13 (TGF-13) Activation and Fibroblast Differentiation [J]. J Biol Chem, 2015, 290 (22) : 13763 - 13778.
  • 7Nackiewicz D, Dan M, lie W, et al. TLR2/6 and TLR4 - activated macrophages contribute to islet inflammation and impair beta cell insulin gene expression via IL- 1 and IL-6 [ J ]. Diabetologia, 2014, 57 (8): 1645-1654.
  • 8Lukic L, Lalic NM, Rajkovic N, et al. Hypertension in obese type 2 diabetes patients is associated with increases in insulin resistance and IL-6 cytokine levels: potential targets for an efficient preventive intervention [J]. Int J Environ Res Public Health, 2014, 11 (4) : 3586 -3598.
  • 9Karabela G, Karavolias G, Chaidaroglou A, et al. Is IL - 10 a predictor of in - stent restenosis in stable and unstable angina patients undergoing coronary interventions.'? [J]. lnt J Cardiol, 2014, 176 (3): 1156-1157.
  • 10Perumal R, Rajendran M, Krishnamurthy M, et al. Modulation of P- selection and platelet aggregation in chronic periodontitis: A clinical study [ J ]. J Indian Soc Periodontol, 2014, 18 (3) : 293.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部